Clinical and Mechanistic Study of Subanesthetic-dose Esketamine in Modified Electroconvulsive Therapy for Adolescents With Severe Depression
Phase: EARLY_PHASE1 | Sponsor: Min Su | Compound: Ketamine
- Status
- planned
- Institution
- Min Su
- Start date
- 2025-11-30
- End date
- 2026-12-20
- Registry ID
- NCT07247968
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.